HNP Capital’s Zimmer Biomet ZBH Stock Holding History

HNP Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,078	Closed	-$553K	–	298
2020 Q1	$553K	Buy	+5,078	New	+$666K	0.08%	136

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

HNP Capital's ZBH Position: Q2 2020 in Review

HNP Capital sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 5,078 shares — an estimated $553K sold.

HNP Capital first reported a position in ZBH in Q1 2020 and held it in 1 quarter. The position peaked at $553K in Q1 2020. 945 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

HNP Capital reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
HNP Capital sold 5,078 Zimmer Biomet shares in Q2 2020, an estimated $553K.
HNP Capital first reported a position in Zimmer Biomet in Q1 2020 and held it in 1 quarter.
HNP Capital's Zimmer Biomet position peaked at $553K in Q1 2020.
945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on HNP Capital's 13F filing for Q2 2020, filed 6 Jul 2020.